Literature DB >> 1982706

The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin.

C Meijer1, N H Mulder, E G de Vries.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1982706     DOI： 10.1016/0305-7372(90)90081-p

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  10 in total

1.  p53 expression and resistance against paclitaxel in patients with metastatic breast cancer.

Authors:  M Schmidt; A Bachhuber; A Victor; E Steiner; M Mahlke; H A Lehr; H Pilch; W Weikel; P G Knapstein
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-25       Impact factor: 4.553

2.  99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.

Authors:  N H Hendrikse; E J Franssen; W T van der Graaf; C Meijer; D A Piers; W Vaalburg; E G de Vries
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

3.  Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients.

Authors:  M Bakker; J P Droz; A R Hanauske; J Verweij; A T van Oosterom; H J Groen; M A Pacciarini; L Domenigoni; F van Weissenbruch; E Pianezzola; E G de Vries
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

4.  Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.

Authors:  Navin Sarin; Florian Engel; Ganna V Kalayda; Mareike Mannewitz; Jindrich Cinatl; Florian Rothweiler; Martin Michaelis; Hisham Saafan; Christoph A Ritter; Ulrich Jaehde; Roland Frötschl
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

5.  TOR Complex 2-Regulated Protein Kinase Fpk1 Stimulates Endocytosis via Inhibition of Ark1/Prk1-Related Protein Kinase Akl1 in Saccharomyces cerevisiae.

Authors:  Françoise M Roelants; Kristin L Leskoske; Ross T A Pedersen; Alexander Muir; Jeffrey M-H Liu; Gregory C Finnigan; Jeremy Thorner
Journal:  Mol Cell Biol       Date:  2017-03-17       Impact factor: 4.272

Review 6.  Modulation of cis-diamminedichloroplatinum(II) resistance: a review.

Authors:  H Timmer-Bosscha; N H Mulder; E G de Vries
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

7.  Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.

Authors:  A G van der Zee; B van Ommen; C Meijer; H Hollema; P J van Bladeren; E G de Vries
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

8.  Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.

Authors:  M W Sark; H Timmer-Bosscha; C Meijer; D R Uges; W J Sluiter; W H Peters; N H Mulder; E G de Vries
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

9.  Glutathione-S-transferase activity and isoenzyme levels measured by two methods in ovarian cancer, and their value as markers of disease outcome.

Authors:  E C Wrigley; A T McGown; H Buckley; A Hall; D Crowther
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

10.  Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.

Authors:  S Naito; S Hasegawa; A Yokomizo; H Koga; S Kotoh; M Kuwano; J Kumazawa
Journal:  Jpn J Cancer Res       Date:  1995-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.